Loading...
Synergy of Histone-Deacetylase Inhibitor AR-42 with Cisplatin in Bladder Cancer
PURPOSE: Cisplatin based chemotherapy regimens form the basis of systemic bladder cancer treatment, although they show limited response rates and efficacy. Recent molecular analysis of bladder cancer revealed a high incidence of mutations in chromatin regulatory genes, suggesting a therapeutic avenu...
Na minha lista:
| Udgivet i: | J Urol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6371809/ https://ncbi.nlm.nih.gov/pubmed/25748177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2015.02.2918 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|